Efficacy of Shenqi Pollen Capsules for High-Altitude Deacclimatization Syndrome via Suppression of the Reoxygenation Injury and Inflammatory Response

Table 2

Primary outcomes for research worker-rated HADAS scores.

	Placebo group ()	SPC group ()	Mean difference from placebo^†	value	value^‡	value^§	value^||
Baseline	12.80 (0.28, 12.25-13.34)	13.08 (0.28, 12.52-13.63)
Week 7	5.26 (0.16, 4.96 - 5.59)	3.95 (0.16, 3.64 - 4.26)	-1.34 (0.20, -1.74- -0.95)	<0.001
Week 14	2.80 (0.12, 2.57 - 3.04)	1.36 (0.12, 1.13 - 1.58)	1.47 (0.20, -1.87- -1.07)	<0.001
Collapsed across time, baseline to week 14					<0.001	<0.001	<0.001

^†Values are the adjusted mean change (SE, 95% CI). Comparisons of the mean differences were made at weeks 7 and 14 from the final adjusted linear mixed model, . ^‡The overall change over time, . ^§The average group difference, . ^||The interaction between time and group, .